DEXTER CORP
10-Q, 1997-11-07
PAINTS, VARNISHES, LACQUERS, ENAMELS & ALLIED PRODS
Previous: DELTA AIR LINES INC /DE/, 4, 1997-11-07
Next: DOW JONES & CO INC, 10-Q, 1997-11-07



<PAGE>   1
                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                    FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
    ACT OF 1934

For the quarterly period ended September 30, 1997
                                       OR

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
    EXCHANGE ACT OF 1934

For the transition period from ______________ to ___________________



Commission file number   1-5542

THE DEXTER CORPORATION
(Exact name of registrant as specified in its charter)

CONNECTICUT                                             06-0321410
(State or other jurisdiction of                      (I.R.S. Employer
incorporation or organization)                        Identification No.)

ONE ELM STREET, WINDSOR LOCKS, CONNECTICUT                  06096
(Address of principal executive offices)                  (Zip Code)

(860) 292-7675
(Registrant's telephone number, including area code)

N/A
(Former name, former address and former fiscal year, if changed since last
report.)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days.   Yes..X.....   No.......

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.

<TABLE>
<CAPTION>
        CLASS                                       Outstanding at October 31, 1997
<S>                                                 <C>
COMMON STOCK, PAR VALUE $1                                  23,162,255 SHARES
</TABLE>
<PAGE>   2
                                     PART I

                              FINANCIAL INFORMATION

Item 1 - Financial Statements

             Reference is made to the following consolidated financial
             statements which are incorporated herein by reference:

              (a) Exhibit 99a -- Condensed Statement of Income for the three
                  months and nine months ended September 30, 1997 and 1996.

              (b) Exhibit 99b -- Condensed Statement of Financial Position as of
                  September 30, 1997, December 31, 1996, and September 30, 1996.

              (c) Exhibit 99c -- Condensed Statement of Cash Flows for the nine
                  months ended September 30, 1997 and 1996.

              (d) Exhibit 99d -- Net Sales by Market for the three months and
                  nine months ended September 30, 1997 and 1996.

              (e)  Exhibit 99e -- Notes to Consolidated Financial Statements.

             The unaudited financial data included herein as of September 30,
             1997 and 1996, and for the three and nine month periods then ended,
             have been reviewed by the registrant's independent public
             accountants, Coopers & Lybrand L.L.P., and their report is
             attached.


Item 2 - Management's Discussion and Analysis of Financial Condition and Results
         of Operations

Analysis of Operations

The Company reported that earnings per share increased 24% to $.62 per share
from $.50 per share in the third quarter of 1996 on a sales increase of 6%.
Earnings increased 21% to a third quarter record of $14.2 million from $11.7
million in the same period last year.

Sales of $286.9 million were a third quarter record and increased 6% compared
with sales of $269.5 million in the third quarter last year. A strong 8%
increase in unit volume and a 2% increase due to acquisitions were partially
offset by a 4% unfavorable effect of currency translation rates.

Sales for the nine-month period ended September 30, 1997, were $852.4 million, a
2% increase compared with sales of $832.4 million for the same period last year.
An increase in unit volume of 6% was partially offset by a 3% unfavorable effect
of currency translation rates and a 1% decrease due to the net effect of
acquisitions and divestitures.
<PAGE>   3
Item 2 - Management's Discussion and Analysis of Financial Condition and Results
         of Operations, continued

Earnings for the nine-month period of 1997 were a record $43.1 million, or $1.87
per share. This represents a 19% increase in earnings from operations and a 22%
increase in earnings per share from operations compared with the results from
operations for the same period last year of $36.3 million, or $1.53 per share.
Total net income for the nine months ended September 30, 1996, of $37.3 million,
or $1.57 per share, included a $.04 per share gain from the disposal of product
lines.

Products with strong performance in the third quarter and nine months ended
September 30, 1997 include aerospace adhesive materials, electronic
encapsulation materials, nonwoven materials serving the European food market,
and sales of products at Life Technologies, Inc. Products with weaker
performance for the quarter and year-to-date include food and beverage can
coatings serving international markets and medical nonwoven materials in the
domestic market.

Consolidated gross margin of 36.3% of net sales in the third quarter of 1997
improved 2.0 percentage points from 34.3% in the same period last year. This 2.0
percentage point improvement resulted from strong volume, favorable product mix,
and productivity improvements at both wholly owned Dexter businesses and at Life
Technologies, Inc. Gross margin on a year-to-date basis was 36%, a 1.7
percentage point improvement over the same period last year.

Marketing and administrative costs increased $4.9 million, or 9%, in the third
quarter, principally due to costs associated with recently acquired businesses
and increased costs at Life Technologies, Inc. On a year-to-date basis,
marketing and administrative costs increased 5%, mostly due to Life
Technologies, Inc.

Other income for the third quarter of 1997 decreased $.8 million, or 26%, due to
lower total equity income resulting from the divestiture of D & S Plastics
International, which was effective April 1, 1997.
<PAGE>   4
Item 2 - Management's Discussion and Analysis of Financial Condition and Results
         of Operations, continued

Analysis of Financial Condition

Other assets as of September 30, 1997 were $49.1 million, a decrease of $38.1
million and $34.5 million compared with December 31, 1996 and September 30,
1996, respectively. These decreases were primarily due to the divestiture of the
Company's 50% equity interest in D & S Plastics International, which was
effective April 1, 1997.

Current installments of long-term debt as of September 30, 1997 were $31.6
million, an increase of $19.3 million and $18.9 million compared with December
31, 1996 and September 30, 1996, respectively. These increases principally
relate to the Company's 9.25% sinking fund debentures and are due to a
prepayment of $15 million which will occur in November 1997 and a prepayment of
$5 million to be made in December 1997. Long-term debt of $168.5 million as of
September 30, 1997 decreased $41.5 million and $40.4 million compared with
December 31, 1996 and September 30, 1996, respectively. These decreases were
primarily due to the abovementioned reclasses to current installments of
long-term debt and a $15 million prepayment in August 1997 of the Company's
9.25% sinking fund debentures.

Treasury stock as of September 30, 1997 was $52.5 million, an increase of $16.8
million compared with $35.7 million at December 31, 1996 and an increase of
$21.5 million compared with $31 million at September 30, 1996. In 1997, the
Company purchased 671,200 shares of its outstanding common stock at an average
price of $30.54 per share. In the fourth quarter 1996, the Company purchased
160,400 shares of its outstanding common stock at an average of $32.54 per
share.
<PAGE>   5
                                     PART II

                                OTHER INFORMATION


Item 6 - Exhibits and Reports on Form 8-K

      (a)   Exhibit 15 of Part 1 -- Letter to Securities and Exchange
            Commission re: Incorporation of Accountants' Report

            Exhibit 27 of Part 1 -- Financial Data Schedule

            Exhibit 99 of Part 1 -- Third Quarter 1997 Financial Statements and
            Notes

      (b)   No reports on Form 8-K were filed during the quarter for which
            this report was filed.
<PAGE>   6
                                   SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.



                                            THE DEXTER CORPORATION
                                            (Registrant)

        November 7, 1997                     /s/ Kathleen Burdett
Date___________________________             ___________________________________
                                            Kathleen Burdett
                                            Vice President and
                                            Chief Financial Officer
                                            (Principal Financial Officer)
<PAGE>   7
                                INDEX TO EXHIBITS







Exhibit No.

     15           Letter to Securities and Exchange Commission re: Incorporation
                  of Accountants' Report

     27           Financial Data Schedule

     99           Third Quarter 1997 Financial Statements and Notes

<PAGE>   1
                                                                      Exhibit 15











Securities and Exchange Commission
450 5th Street, N.W.
Judiciary Plaza
Washington, D.C. 20549

We are aware that our report dated October 15, 1997, on our review of the
interim financial information of The Dexter Corporation as of September 30, 1997
and 1996, and for the three and nine month periods then ended, and included in
this Form 10-Q is incorporated by reference in the company's registration
statements on Form S-8, Registration Nos. 2-63959, 33-27597, 33-53307,
33-53309, 333-02985, and 333-04081. Pursuant to Rule 436(c) under the Securities
Act of 1933, this report should not be considered a part of the registration
statements prepared or certified by us within the meaning of Sections 7 and 11
of that Act.



/s/ Coopers & Lybrand L.L.P.
COOPERS & LYBRAND L.L.P.


Springfield, Massachusetts
November 7, 1997

<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
Condensed Statement of Financial Position and Condensed Statement of Income and
is qualified in its entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-END>                               SEP-30-1997
<CASH>                                          86,501
<SECURITIES>                                         0
<RECEIVABLES>                                  196,585
<ALLOWANCES>                                     5,966
<INVENTORY>                                    160,851
<CURRENT-ASSETS>                               483,245
<PP&E>                                         701,220
<DEPRECIATION>                                 357,919
<TOTAL-ASSETS>                                 952,037
<CURRENT-LIABILITIES>                          249,409
<BONDS>                                        168,459
                                0
                                          0
<COMMON>                                        24,984
<OTHER-SE>                                     342,652
<TOTAL-LIABILITY-AND-EQUITY>                   952,037
<SALES>                                        852,413
<TOTAL-REVENUES>                               861,688
<CGS>                                          545,300
<TOTAL-COSTS>                                  545,300
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              15,585
<INCOME-PRETAX>                                 84,557
<INCOME-TAX>                                    30,441
<INCOME-CONTINUING>                             43,112
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    43,112
<EPS-PRIMARY>                                     1.87
<EPS-DILUTED>                                        0
        

</TABLE>

<PAGE>   1
                                  EXHIBIT 99a
CONDENSED STATEMENT OF INCOME                             THE DEXTER CORPORATION

<TABLE>
<CAPTION>
- ---------------------------------------------------------------------------------------------------
                                   Three Months Ended September 30   Nine Months Ended September 30
In thousands of dollars            -------------------------------   ------------------------------
(except per share amounts)           1997       1996     Change         1997       1996   Change
- ---------------------------------------------------------------------------------------------------
<S>                                <C>        <C>         <C>        <C>        <C>        <C>
REVENUES
Net sales                          $286,928   $269,493     + 6%      $852,413   $832,421   + 2%
Other income                          2,349      3,182     -26%         9,275      8,379   +11%
                                   --------   --------               --------   --------
                                    289,277    272,675     + 6%       861,688    840,800   + 2%
EXPENSES
Cost of sales                       182,758    176,997     + 3%       545,300    547,278    
Marketing and administrative         59,698     54,755     + 9%       175,747    167,149   + 5%
Research and development             13,442     12,470     + 8%        40,499     38,488   + 5%
Interest                              5,287      4,929     + 7%        15,585     15,671   - 1%
Gain on divestiture of product
  lines                                                                           (2,719)
                                   --------   --------               --------   --------
INCOME BEFORE TAXES                  28,092     23,524     +19%        84,557     74,933   +13%
Income taxes                         10,113      8,351     +21%        30,441     26,601   +14%
                                   --------   --------               --------   --------
INCOME BEFORE MINORITY INTERESTS     17,979     15,173     +18%        54,116     48,332   +12%
Minority interests                    3,736      3,432     + 9%        11,004     11,050 
                                   --------   --------               --------   --------
NET INCOME                         $ 14,243   $ 11,741     +21%      $ 43,112   $ 37,282   +16%
                                   ========   ========               ========   ========

NET INCOME PER SHARE                  $0.62      $0.50     +24%         $1.87      $1.57   +19%

DIVIDENDS DECLARED PER SHARE          $0.24      $0.22     + 9%         $0.72      $0.66   + 9%

AVERAGE SHARES OUTSTANDING (000)     22,914     23,545     - 3%        23,037     23,733   - 3%
- ---------------------------------------------------------------------------------------------------
</TABLE>
See accompanying notes to the consolidated financial statements.

Amounts are unaudited.

<PAGE>   2
                                  EXHIBIT 99b

                                                          THE DEXTER CORPORATION
CONDENSED STATEMENT OF FINANCIAL POSITION

<TABLE>
<CAPTION>
- ----------------------------------------------------------------------------------------
In thousands of dollars                      SEPTEMBER 30   DECEMBER 31     SEPTEMBER 30
(except per share amounts)                   -------------------------------------------
                                                     1997          1996             1996
- ----------------------------------------------------------------------------------------
<S>                                          <C>            <C>            <C>
ASSETS
Cash and short-term securities                   $ 86,501      $103,420         $ 82,356
Accounts receivable, net                          203,265       178,093          200,546
Inventories              
  Materials and supplies                           59,860        58,290           57,085
  In process and finished                         119,622       110,457          107,177
  LIFO reserve                                    (18,631)      (19,836)         (21,231)
                                                 --------      --------         --------
                                                  160,851       148,911          143,031
Prepaid and deferred expenses                      32,628        29,987           31,882
                                                 --------      --------         --------
  Total current assets                            483,245       460,411          457,815

Property, plant and equipment, at cost, net       343,301       334,266          321,912
Excess of cost over net assets of
  business acquired                                76,373        71,906           74,805
Other assets                                       49,118        87,221           83,575
                                                 --------      --------         --------
                                                 $952,037      $953,804         $938,107
                                                 ========      ========         ========

LIABILITIES & SHAREHOLDERS' EQUITY
Short-term debt                                  $  3,705      $  5,111         $  5,501
Current installments of long-term debt             31,553        12,297           12,649
Accounts payable                                   98,045        91,855           81,568
Accrued liabilities and taxes                     108,381       101,691          104,089
Current environmental reserves                      2,223         1,358            1,207
Dividends payable                                   5,502         5,170            5,183
                                                 --------      --------         --------
  Total current liabilities                       249,409       217,482          210,197

Long-term debt                                    168,459       209,952          208,839
Deferred items                                     51,394        46,874           48,316
Long-term environmental reserves                   14,154        14,978           15,219
Minority interests                                100,985        90,403           85,759

Shareholders' equity
  Common stock and paid-in capital                 36,893        36,495           34,768
  Retained earnings                               402,034       375,480          369,212
  Currency translation effects                    (18,767)       (2,187)          (3,185)
  Treasury stock                                  (52,524)      (35,673)         (31,018)
                                                 --------      --------         --------
    Total shareholders' equity                    367,636       374,115          369,777
                                                 --------      --------         --------
                                                 $952,037      $953,804         $938,107
                                                 ========      ========         ========

EQUITY PER SHARE                                   $16.04        $15.94           $15.69
- ----------------------------------------------------------------------------------------
</TABLE>

See accompanying notes to the consolidated financial statements.

Amounts as of September 30, 1997 and September 30, 1996 are unaudited.
<PAGE>   3
                                   EXHIBIT 99c

                                                          THE DEXTER CORPORATION

<TABLE>
<CAPTION>
CONDENSED STATEMENT OF CASH FLOWS
- -----------------------------------------------------------------------------------------

                                                           Nine Months Ended September 30
                                                           ------------------------------
In thousands of dollars                                         1997              1996
- -----------------------------------------------------------------------------------------
<S>                                                        <C>                <C>
OPERATIONS
Net income                                                   $  43,112         $ 37,282
    Noncash items
        Depreciation and amortization                           33,955           33,537
        Gain on divestiture of product lines                                     (2,719)
        Income taxes not due                                     1,453           10,839
        Minority interests                                      11,004           11,050
        LIFO inventory credit                                   (1,205)          (3,478)
        Equity in net income of affiliates                      (3,520)          (3,196)
        Other                                                      674            3,658
Operating working capital increase                             (27,508)          (2,886)
                                                             ---------         --------
                                                                57,965           84,087
                                                             ---------         --------
INVESTMENTS
Property, plant and equipment                                  (45,092)         (38,455)
Acquisitions                                                   (20,661)         (16,198)
Divestitures                                                    41,539           34,913
Joint ventures                                                   2,102            4,047
Proceeds from exercise of LTI stock options                      3,164            1,736
Other                                                            3,258           (3,853)
                                                             ---------         --------
                                                               (15,690)         (17,810)
                                                             ---------         --------
FINANCING
Long-term debt                                                 (21,197)          (6,576)
Short-term debt, net                                            (1,256)          (8,035)
Dividends paid                                                 (16,226)         (15,782)
LTI dividends paid to minority interest shareholders            (1,307)          (1,133)
Purchase of treasury stock                                     (20,517)         (21,434)
Other                                                            3,069            3,718
                                                             ---------         --------
                                                               (57,434)         (49,242)
                                                             ---------         --------
(DECREASE) INCREASE IN CASH AND SHORT-TERM SECURITIES        $ (15,159)        $ 17,035
                                                             =========         ========

RECONCILIATION OF (DECREASE) INCREASE  IN
   CASH AND SHORT-TERM SECURITIES
Cash and short-term securities at beginning of period        $ 103,420         $ 65,542
Cash and short-term securities at end of period                 86,501           82,356
                                                             ---------         --------
(Decrease) Increase in cash and short-term securities
     per Statement of Financial Position                       (16,919)          16,814
Currency translation effects                                     1,760              221
                                                             ---------         --------
                                                             $ (15,159)        $ 17,035
                                                             =========         ========


INTEREST PAID                                                $  14,178         $ 16,338

TAXES PAID                                                   $  28,988         $ 15,762
- ----------------------------------------------------------------------------------------
</TABLE>

See accompanying notes to the consolidated financial statements.

Amounts are unaudited.
<PAGE>   4

                                   EXHIBIT 99d

<TABLE>
<CAPTION>
NET SALES BY MARKET                                                                      THE DEXTER CORPORATION

- ----------------------------------------------------------------------------------------------------------------------
                                Three Months Ended September 30                   Nine Months Ended September 30
                             --------------------------------------          -----------------------------------------
In thousands of dollars           1997            1996     Change               1997          1996          Change
- ----------------------------------------------------------------------------------------------------------------------
<S>                          <C>            <C>            <C>               <C>             <C>            <C>
     AEROSPACE               $  15,906      $   13,102       + 21%           $    45,090     $  37,635         + 20%


     ELECTRONICS                55,577          47,136       + 18%               159,426       144,614         + 10%


     FOOD PACKAGING (1)         70,522          68,276       +  3%               207,800       205,781         +  1%


     MEDICAL                   106,031         102,111       +  4%               320,597       303,396         +  6%


     OTHER (2)                  38,892          38,868                           119,500       140,995         - 15%
                             ----------     -----------                      -----------     ---------

     CONSOLIDATED            $ 286,928      $  269,493       +  6%           $   852,413     $ 832,421         +  2%
                             ==========     ===========                      ===========     =========
- -----------------------------------------------------------------------------------------------------------------------
</TABLE>

(1)   The effect of businesses acquired increased net sales to the Food
      Packaging market by $5.1 million, or 8%, for the quarter, and $12.9
      million, or 6%, year-to-date.

(2)   The effect of businesses divested decreased net sales in the "Other"
      category by $19.3 million, or 14%, year-to-date.


Amounts are unaudited.



<PAGE>   5
                                   Exhibit 99e


                             The Dexter Corporation
                   Notes to Consolidated Financial Statements


Note 1  --     In the opinion of the company's management, the unaudited
               financial statements reflect adjustments of a normal recurring
               nature which are necessary to present a fair statement of the
               results for the interim periods. The notes to the consolidated
               financial statements including management's discussion in Part 1,
               Item 2 of this Form 10-Q are incorporated as part of these
               consolidated financial statements. The year-end condensed balance
               sheet data was derived from the audited financial statements.

Note 2 --      Net income per share figures in the consolidated Condensed
               Statement of Income are based on the weighted average number of
               shares outstanding as indicated for each period. No effect has
               been given to stock options or restricted stock awards
               outstanding as no material dilutive effect would result from the
               inclusion of these items.

Note 3  --     In February 1997, the Financial Accounting Standards Board issued
               Statement of Financial Accounting Standards No. 128, Earnings per
               Share (the "Statement"), which is required to be adopted on
               December 31, 1997. At that time, the Company will be required to
               change the method currently used to compute earnings per share
               and to restate all prior periods. The impact of the Statement on
               the calculation of earnings per share amounts for the three and
               nine month periods ended September 30, 1997 and 1996 is not
               expected to be material.

               In June 1997, the Financial Accounting Standards Board issued
               Statement of Financial Accounting Standards No. 130, Reporting
               Comprehensive Income and Statement of Financial Accounting
               Standards No. 131, Disclosures about Segments of an Enterprise
               and Related Information (the "Statements"), which become
               effective for financial statements for periods beginning after
               December 15, 1997. The Company is currently evaluating the impact
               of these Statements on its financial reporting practices.

Note 4 --      The following are included as components of Common Stock and
               Paid-in Capital.

<TABLE>
<CAPTION>
COMMON STOCK & PAID-IN CAPITAL   SEPTEMBER 30,    DECEMBER 31,   SEPTEMBER 30,
(IN THOUSANDS OF DOLLARS)            1997            1996            1996
- ------------------------------     --------        --------        --------
<S>                               <C>             <C>             <C>
Common stock                       $ 24,984        $ 24,984        $ 24,984
Paid-in capital                      17,111          14,669          13,938
Unrealized losses on
  investments                          (427)           (174)           (350)
Unearned compensation on
  restricted stock                   (4,571)         (2,780)         (3,331)
Pension liability adjustment           (204)           (204)           (473)
                                   --------        --------        --------
                                   $ 36,893        $ 36,495        $ 34,768
                                   ========        ========        ========
</TABLE>


<PAGE>   6
                        REPORT OF INDEPENDENT ACCOUNTANTS


To the Shareholders and Board of Directors of
The Dexter Corporation

We have reviewed the accompanying condensed statement of financial position of
The Dexter Corporation as of September 30, 1997 and 1996, and the related
condensed statement of income for the three and nine month periods then ended,
and condensed statement of cash flows for the nine month periods then ended.
These financial statements are the responsibility of the company's management.

We conducted our review in accordance with standards established by the American
Institute of Certified Public Accountants. A review of interim financial
information consists principally of applying analytical procedures to financial
data and making inquiries of persons responsible for financial and accounting
matters. It is substantially less in scope than an audit conducted in accordance
with generally accepted auditing standards, the objective of which is the
expression of an opinion regarding the financial statements taken as a whole.
Accordingly, we do not express such an opinion.

Based on our review, we are not aware of any material modifications that should
be made to the accompanying financial statements for them to be in conformity
with generally accepted accounting principles.

We have previously audited, in accordance with generally accepted auditing
standards, the consolidated statement of financial position of The Dexter
Corporation as of December 31, 1996, and the related consolidated statements of
income, cash flows, and changes in shareholders' equity for the year then ended
(not presented herein); and in our report dated February 4, 1997, we expressed
an opinion which included an explanatory paragraph regarding the adoption of
SFAS No. 121, Accounting for the Impairment of Long-Lived Assets and for
Long-Lived Assets to be Disposed Of, and SFAS No. 123, Accounting for
Stock-Based Compensation on those consolidated financial statements. In our
opinion, the information set forth in the accompanying condensed statement of
financial position as of December 31, 1996, is fairly stated, in all material
respects, in relation to the consolidated statement of financial position from
which it has been derived.


/s/ Coopers & Lybrand L.L.P.
COOPERS & LYBRAND L.L.P.


Springfield, Massachusetts
October 15, 1997



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission